1 completed, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Hepatitis Delta Virus: new trials by email Literature Review of Hepatitis Delta Virus trials Research Report on Hepatitis Delta Virus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV Peginterferon Lambda-1a - Hepatitis Delta Virus | Phase 3 | Unknown | Eiger BioPharmaceuticals | 150 | 2021-12-21 | 2023-08-25 |
| Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a Lonafarnib, Ritonavir, PEG IFN-alfa-2a - Hepatitis Delta Virus | Phase 3 | Completed | Eiger BioPharmaceuticals | 407 | 2018-12-01 | 2023-04-14 |
Hepatitis D (2)
Digestive System Diseases (2) · Hepatitis (2) · Hepatitis, Viral, Human (2) · Infections (2) · Liver Diseases (2) · RNA Virus Infections (2) · Virus Diseases (2)
Ritonavir (1) · lonafarnib (1) · peginterferon alfa-2a (1) · peginterferon lambda-1a (1)
Belgium (2) · Bulgaria (2) · France (2) · Germany (2) · Israel (2) · Italy (2) · Moldova (2) · Romania (2) · Spain (2) · Turkey (Türkiye) (2) · United States (2) · Canada (1) · Georgia (1) · Greece (1) · Mongolia (1)